Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Invitrogen eBioscience human antibodies are available conjugated to a variety of fluorophores to enable multicolor flow cytometry, functional assays, and immunohistochemistry applications. Additional antibodies to other human antigens including novel cell-surface molecules are in our pipeline.
This guide provides detailed marker information for immune cell types and subtypes for both human and mouse for immune cells, stem cells, and other cell types.
Antigen name | Other names | MW | Structure | Distribution | Function |
---|---|---|---|---|---|
CD1a | T6 | 49kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC | antigen presentation, with beta2m |
CD1b | T6 | 45kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC | antigen presentation, with beta2m |
CD1c | T6 | 43kD | IgSF, MHC-like | cortical thymocytes, Langerhans cells, DC, B subset | antigen presentation, with beta2m |
CD1d | 49kD | IgSF, MHC-like | intestinal epith, B subset, monolow, DC | antigen presentation, with beta2m | |
CD1e | 28kD | IgSF, MHC-like | DC | antigen presentation, with beta2m | |
CD2 | T11, LFA-2, SRBC-R | 45-58kD | IgSF | thymocytes, T, NK | CD58 ligand, adhesion, T cell activation |
CD2R | T11-3 | 50kD | IgSF | Tact | activation-dependent form of CD2 |
CD3 gamma, CD3 delta | T3 | 20-30kD | IgSF | T, thymocyte subset | with TCR, TCR surface expression / signal transduction |
CD3 epsilon | T3 | 20kD | IgSF | thymocytes, T cell subsets | with TCR, TCR surface expression / signal transduction |
CD4 | T4 | 55kD | IgSF | thymocyte subset, T subset, mono, mac | MHC class II coreceptor, HIV receptor, T cell differentiation / activation |
CD5 | T1, Tp67 | 67kD | Scavenger R SF | thymocytes, T, B subset, B-CLL | CD72 receptor, TCR or BCR signaling, T-B interaction |
CD6 | T12 | 100-130kD | Scavenger R SF | thymocytes, T cells, B cell subsets | CD166 receptor, T cell differentiation / costimulation |
CD7 | 40kD | IgSF | hematopoietic progenitors, thymocytes, T, NK | T cell costimulation; marker for T cell acute lymphatic leukemia and pluripotential stem cell leukemias | |
CD8a | T8, Leu-2 | 32-34kD | IgSF | thymocyte subset, T subset, NK | MHC class I coreceptor, receptor for some mutated HIV-1, T cell differentiation / activation |
CD8b | 32-34kD | IgSF | thymocyte subset, T subset | MHC class I coreceptor, receptor for some mutated HIV-1, T cell differentiation / activation | |
CD9 | p24, MRP-1 | 22-27kD | TM4SF | pre-B, eosinophils, basophils, platelets, Tact, brain and peripheral nerves, vascular smooth muscle | cellular adhesion and migration; mediates platelet aggregation |
CD10 | CALLA, NEP, gp100 | 100kD | type II TM | B and T-cell precursors, bone marrow stromal cells | zinc-binding metalloproteinase, B cell development |
CD11a | LFA-1, integrin alphaL | 180kD | Integrin family | lymph, gran, mono, mac | CD11a / CD18 receptor for ICAM-1, -2,-3, intercellular adhesion, T costimulation |
CD11b | Mac-1, integrin alphaM | 170kD | Integrin family | myeloid cells, NK | binds CD54, ECM, iC3b |
CD11c | p150, 95, CR4, integrin alphaX | 150kD | Integrin family | DC, myeloid cells, NK, B, T subset | binds CD54, fibrinogen and iC3b |
CD12 | 90-120kD | mono, gran, platelets | unknown | ||
CD13 | Aminopeptidase N, APN | 150-170kD | type II TM | myelomonocytic cells | zinc-binding metalloproteinase, antigen processing, receptor for corona virus strains |
CD14 | LPS-R | 53-55kD | GPI-linked | mono, mac, Langerhans cells, gran, myelomonocytic cells | receptor for LPS/LBP, LPS recognition |
CD15 | Lewis-x, Lex | CHO | neutrophils, eosinophils, mono | terminal trisaccharide expressed on glycolipids and many cell-surface glycoproteins, cell adhesion | |
CD15s | Sialyl Lewis X | CHO | neutrophils, eosinophils, mono, memory helper T, Tact and B, NK, HEV | CD62L and CD62P ligand, adhesion | |
CD15u | Sulfated Lewis X | CHO | myeloid subset | sulphated CD15, cell adhesion | |
CD16a | FcgammaRIIIA | 50-65kD | IgSF | neutrophils, mac, NK | component of low affinity Fc receptor, phagocytosis and antibody-dependent cell-mediated cytotoxicity |
CD16b | FcgammaRIIIB | 48kD | IgSF | neutrophils | component of low affinity Fc receptor, phagocytosis and ADCC |
CD17 | neutrophils, mono, platelets | lactosyl ceramide, a cell-surface glycosphingolipid | |||
CD18 | Integrin beta2 | 95kD | Integrin family | broad, all leukocytes | with CD11a, b & c, adhesion |
CD19 | B4 | 95kD | IgSF | B, FDC | complex with CD21 and CD81, BCR coreceptor, B cell activation / differentiation |
CD20 | B1, Bp35 | 33-37kD | TM4SF | B, T subset | B cell activation |
CD21 | C3DR, CR2, EBV-R | 145,110kD | CCRSF | mature B cells, follicular dendritic cells, T subsets | complement C3d and EBV receptor, complex with CD19 and CD81, BCR coreceptor |
CD22 | BL-CAM, Siglec-2 | 150kD | IgSF, sialoadhesins | mature B cells | bBinds sialoconjugates, cell adhesion, B mono, B T interactions |
CD23 | FcepsilonRII | 45kD | C-type lectin | B, activated mac, eosinophils, FDC, platelets | CD19-CD21-CD81 receptor, IgE low affinity receptor, signal transduction |
CD24 | BA-1 | 35-45kD | GPI-linked | thymocytes, erythrocytes, peripheral lymph, myeloid, B cells, granulocytes | binds P-selectin |
CD25 | Tac, p55 | 55kD | type I TM | activated B and T cells, macrophages, lymph progenitors, monocytes | IL-2Ralpha, with IL-2Rbeta and gamma to form high affinity complex |
CD26 | DPP IV | 110kD | type II TM | activated B and T cells, macrophages, Thymocyte subset | dipeptidyl peptidase, T costimulation, HIV entry |
CD27 | T14 | 50-55kD | TNFRSF | medullary thymocytes, T, B subset, NK subset | CD70 receptor, costimulator for B and T cells |
CD28 | Tp44, T44 | 44kD | IgSF | most T, thymocytes, plasma cells | CD80, CD86 receptor, T costimulation |
CD29 | Integrin beta1 | 130kD | Integrin family | lymph, mono, gran, platelets, mast cells, fibroblasts, endothelial cells | with CD49a (VLA-1) receptor for VCAM-1, MAdCAM-1 and ECM |
CD30 | Ki-1 | 105-120kD | TNFRSF | Bact, T and NK , Reed-Sternberg cells, anaplastic large cell lymphoma | CD153 receptor, lymph proliferation /apoptosis, adhesion molecule, mediating both leukocyte-endothelial and endothelial-endothelial interactions |
CD31 | PECAM-1 | 130-140kD | IgSF | mono, platelets, gran, endoth, lymph subset | CD38 receptor, adhesion |
CD32 | FcgammaRII | 40kD | IgSF | mono, gran, B, platelets | low affinity Fc receptor for aggregated Ig and immune complexes |
CD33 | p67, Siglec-3 | 67kD | IgSF, sialoadhesins | myeloid progenitors, mono, gran, DC, mast cells, Tact | cell adhesion, binds sialoconjugates |
CD34 | 105-120kD | Sialomucin, type I TM | hematopoietic precursors, capillary endoth, embryonic fibroblasts | stem cell marker, adhesion, CD62L receptor | |
CD35 | CR1 | 250kD | CCRSF | erythrocytes, B, mono, neutrophils, eosinophils, FDC, T subset | complement receptor 1, binds C3b and C4b, adhesion, phagocytosis |
CD36 | GPIV | 88kD | platelets, mono, mac, endoth, early erythrocytes | ECM receptor, adhesion, phagocytosis | |
CD37 | 40-52kD | TM4SF | mature B cells, mature T cells, myeloid cells | signal transduction | |
CD38 | T10 | 45kD | variable levels on majority of hematopoietic cells,high expression on plasma cells, early B and T cells, activated T cells, germinal center B cells, plasma cells | ecto-ADP-ribosyl cyclase, cell activation | |
CD39 | 78kD | NK, mac, Langerhans cells, DC, Bact | B cell adhesion, protects activated cells from lysis, ecto-apyrase | ||
CD40 | 48kD | TNFRSF | B cells, macrophages, dendritic cells, basal epithelial cells | CD154 receptor, B differentiation / costimulation, isotype-switching, rescues B cells from apoptosis | |
CD41 | gpIIb | dimer: GPIIba:125, GPIIbb:22 | Integrin family | platelets, megakaryocytes | with CD61 forms GPIIb, binds fibrinogen, fibronectin, vWF, thrombospondin, platelet activation and aggregation |
CD42a | GPIX | 22kD | LRRF | platelets, megakaryocytes | complex with CD42b, c and d, receptor for vWF and thrombin, platelet adhesion to subendothelial matrices |
CD42b | GPIba | 145kD | LRRF | platelets, megakaryocytes | complex with CD42a, c and d, binds to vWF and thrombin, platelet adhesion / activation |
CD42c | GPIbb | 24kD | LRRF | platelets, megakaryocytes | complex with CD42a, b, d |
CD42d | GPV | 82kD | LRRF | platelets, megakaryocytes | complex with CD42a-c |
CD43 | Leukosialin, sialophorin | 115-135kD | Sialomucin, type I TM | leukocytes, except resting B, plateletslow | inhibition of T cell interaction, CD54R, adhesion |
CD44 | H-CAM, Pgp-1 | 80-95kD | hyaladherin family | hematopoietic and non-hematopoietic cells, except platelets, hepatocytes, testis | binds hyaluronic acid, adhesion |
CD44v | CD44 variants heterogeneous expression, constitutively on epith, mono, upregulated on activated leukocytes | adhesion, metastasis | |||
CD45 | LCA, T200, B220 | 180-240kD | hematopoietic cells, multiple isoforms from alternative splicing | tyrosine phosphatase, enhanced TCR & BCR signals | |
CD45RA | 205-220kD | B, T subset(naive), mono | exon A isoforms of CD45 | ||
CD45RB | T200 | 190-220kD | T subset, B, mono, mac, gran | exon B isoforms of CD45 | |
CD45RO | 180kD | Tact, memory T, B subset, mono, mac, gran | isoform of CD45 lacking A, B, C exons | ||
CD46 | MCP | 56/66kD | CCRSF | hematopoietic and nonhematopoietic nucleated cells | membrane cofactor protein, binds C3b & C4b allowing degradation by Factor I, measles virus receptor |
CD47 | IAP, MER6, OA3 | 47-52kD | IgSF | hematopoietic cells, epith, endoth, fibroblasts, other tissues | leukocyte adhesion, migration, activation |
CD47R | New designation for CDw149, similar distribution as CD47 but dimmer | ||||
CD48 | Blast-1 | 45kD | IgSF | broad, all leukocytes | cell adhesion |
CD49a | VLA-1 | 200kD | Integrin family | activated T cells, monocytes, neuronal cells, smooth muscle | integrin alpha1, adhesion, CD49a/CD29 binds collagen and laminin |
CD49b | VLA-2 | 160kD | Integrin family | B cells, monocytes, platelets, megakaryocytes, neuronal, epithelial and endothelial cells, osteoclasts | integrin alpha2, adhesion, CD49b / CD29 binds collagen and laminin |
CD49c | VLA-3 | 125kD | Integrin family | B and Tlow, most adhesive cell lines | integrin alpha3, adhesion, CD49c/CD29 binds laminin, fibronectin and collagen |
CD49d | VLA-4 | 150kD | Integrin family | T, B, NK, thymocytes, mono, eosinophils, mast, DC | integrin alpha4, adhesion, CD49d/CD29 binds fibronectin, VCAM-1 & MAdCAM-1 |
CD49e | VLA-5 | 135, 25kD | Integrin family | thymocytes, T, mono, platelets, early and Bact | integrin alpha5, adhesion, CD49e/CD29 binds fibronectin |
CD49f | VLA-6 | 125, 25kD | Integrin family | memory T, thymocytes, mono, platelets, megakaryocytes, epith | integrin alpha6, adhesion, CD49f / CD29 binds laminin |
CD50 | ICAM-3 | 130kD | IgSF | thymocytes, T cells, B cells, monocytes, granulocytes | adhesion, costimulation, binds integrin CD11a/CD18 |
CD51 | Vitronectin receptor | 125, 24kD | Integrin family | platelets, endothelial cells, osteoblasts, melanomas, megakaryocytes | integrin alphav, adhesion, CD51 / CD61 binds vitronectin, vWF, fibrinogen and thrombospondin |
CD52 | CAMPATH-1 | 21-28kD | thymocytes, T, B (not plasma cells), mono, mac | unknown, target for antibodies used therapeutically to deplete T cells from bone marrow | |
CD53 | 35-42kD | TM4SF | leukocytes, DC, osteoblasts, osteoclasts | unknown, maybe signal transduction | |
CD54 | ICAM-1 | 75-115kD | IgSF | hematopoietic and nonhematopoietic cells | receptor for CD11a / CD18 (LFA-1),CD11b/CD18 (Mac-1) and rhinovirus, intracellular adhesion |
CD55 | DAF | 60-70kD | GPI-linked | hematopoietic and nonhematopoietic cells | decay accelerating factor (DAF), binds C3b, complement regulation |
CD56 | NCAM | 135-220kD | IgSF | NK, T subset, neurons, some large granular lymphocyte leukemias, myeloid leukemias | adhesion |
CD57 | HNK-1, Leu-7 | 110kD | NK cells, subsets of T cells, B cells, and monocytes | oligosaccharide, found on many cell-surface glycoproteins | |
CD58 | LFA-3 | 55-70kD | IgSF | hematopoietic, non-hematopoietic cells | leukocyte function-associated antigen-3 (LFA-3), binds CD2, adhesion molecule |
CD59 | hematopoietic and nonhematopoietic cells | 19kD | GPI-linked | hematopoietic, non-hematopoietic cells | binds complement C8 and C9, blocks assembly of membrane attack complex |
CD60a | GD3 | CHO | T subset, platelets, thymic epith, astrocytes | costimulation | |
CD60b | 9-O-sialyl GD3 | CHO | T subset, Bact | 9-O-acetyl-GD3 | |
CD60c | 7-O-sialyl GD3 | CHO | T subset | 7-O-acetyl-GD3 | |
CD61 | GPIIIa | 110kD | Integrin family | platelets, megakaryocytes, mac, endoth | integrin beta3, adhesion, CD41/CD61 or CD51 / CD61 mediate adhesion to ECM |
CD62E | E-selectin, ELAM-1 | 140kD | Selectin family | endothelium | endothelium leukocyte adhesion molecule (ELAM), binds sialyl-Lewis x, mediates rolling interaction of neutrophils |
CD62L | L-selectin, LECAM-1 | 150kD | Selectin family | B, naïve and memory T, mono, gran, NK, thymocytes | CD34, GlyCAM, and MAdCAM-1 receptor, leukocyte homing, tethering, rolling |
CD62P | P-selectin, PADGEM | 140kD | Selectin family | platelets, megakaryocytes, endothelium | CD162, CD15s receptor, adhesion, neutrophil rolling, platelet-neutrophil and platelet-mono interactions |
CD63 | LIMP, LAMP-3 | 53kD | TM4SF | activated platelets, mono, mac | unknown, is lysosomal membrane protein translocated to cell surface after activation |
CD64 | FcgammaRI | 72kD | IgSF | mono, mac, DC, Interferon or G-CSF activated gran | high affinity receptor for IgG, phagocytosis and ADCC |
CD65 | gran, mono subset, myeloid leukemias | oligosaccharide component of a ceramide dodecasaccharide | |||
CD65s | VIM2 | gran, mono, myeloid leukemias | phagocytosis | ||
CD66a | BGP-1, NCA-160 | 160-180kD | IgSF, CEA family | neutrophils, epith | cell adhesion |
CD66b | CD67, CGM6 | 95-100kD | IgSF, CEA family | gran | cell adhesion, neutrophil activation |
CD66c | NCA | 90kD | IgSF, CEA family | neutrophils, colon carcinoma | cell adhesion |
CD66d | CGM1 | 35kD | IgSF, CEA family | neutrophils | |
CD66e | CEA | 180-200kD | IgSF, CEA family | colon epith, colon cancer | cell adhesion |
CD66f | PSG, Sp-1 | 54-72kD | IgSF, CEA family | pregnancy specific glycoprotein, placental syncytiotrophoblasts, fetal liver | immune regulation, protects fetus from maternal immune system |
CD68 | Macrosialin, gp110 | 110kD | Sialomucin | intracellularly in mono, mac, neutrophils, basophils, large lymph, mast cells, DC, myeloid progenitors, liver | Unknown |
CD69 | AIM | 28, 32kD | C-type lectin | Tact, B, NK and gran, thymocytes, platelets, Langerhans cells | unknown, early activation antigen, signal transduction |
CD70 | Ki-24 | 75, 95, 170kD | TNFSF | activated T and B cells, and macrophages | CD27 ligand, T and B cell costimulation |
CD71 | T9 | 95kD | proliferating cells, reticulocytes, erythroid precursors | transferrin receptor, iron uptake | |
CD72 | Lyb-2 | 42kD | C-type lectin | B, FDC | unknown, maybe CD5, CD100 receptor, B proliferation |
CD73 | 69kD | GPI-linked | B cell subsets, T cell subsets | ecto-5’-nucleotidase, nucleoside uptake, T costimulation, lymph adhesion | |
CD74 | Ii, invariant chain | 33, 35, 41, 43kD | B cells, macrophages, monocytes, MHC class II positive cells | MHC class II traffic and function | |
CD75 | CHO Sialoglycan family | B subset, epith | lactosamines | ||
CD75s | CHO Sialoglycan family | B subset, T subset | alpha-2,6-sialylated lactosamines (previously CDw75 and CDw76) | ||
CD77 | Gb3, Pk blood group | germinal center B, Burkitt’s lymphomashigh, follicular lymphomaslow | neutral glycosphingolipid (Galα1→4Galβ1 →4Galcβ1 →ceramide), binds Shiga toxin, cross-linking induces apoptosis | ||
CD79a | Iga | 40–45kD | IgSF | B cells | component of BCR, BCR surface expression and signal transduction |
CD79b | Igb | 37kD | IgSF | B cells | component of BCR, BCR surface expression and signal transduction |
CD80 | B7, B7-1, BB1 | 60kD | IgSF | Bact and Tact, mac, DC | binds to CD28, CD152, T costimulation |
CD81 | TAPA-1 | 26kD | TM4SF | T, B, NK, thymocytes, DC, endoth, fibroblast, neuroblastomas, melanomas | complex with CD19 & CD21, signaling, T costimulation |
CD82 | R2 | 50-53kD | TM4SF | leukocytes | unknown |
CD83 | HB15 | 43kD | IgSF | Bact and Tact, DC, Langerhans cells | unknown |
CDw84 | 73kD | mono, platelets, B, T subset, mac subset | unknown | ||
CD85 | 110kD | IgSF, ILT/LIR family | DC, mono, B, NK, T subset | inhibition of NK, T cell cytolytic function , ILT/LIR family | |
CD85a | LIR3, ILT5, HL9, LILRB3 | 110 kDa | monocytes | activation of NK cell–mediated cytotoxicity, association with FcRγ | |
CD85b | ILT8, LILRA6 | NK cells, T cell subsets, monocytes, macrophages, DCs, B cells | activation of NK cell–mediated cytotoxicity, association with FcRγ | ||
CD85c | LIR8, LILRB5 | NK cells, T cell subsets, monocytes, macrophages, DCs, B cells | suppression of NK cell–mediated cytotoxicity | ||
CD85d | LIR2, ILT4, MIR10, ILT8 | 110kDa | NK cells, monocytes, macrophages | activation of NK cell–mediated cytotoxicity, association with FcRγ | |
CD85e | ILT6, LIR4, LILRA3 | B and NK cells | activation of NK cell–mediated cytotoxicity, association with FcRγ | ||
CD85f | ILT11, LIR9, LILRA5 | monocytes, neutrophils, macrophages, DCs | signaling for cytokine production | ||
CD85g | LIR4, ILT7 | 5 kDa | plasmacytoid DCs | activation of NK cell–mediated cytotoxicity | |
CD85h | LIR7, ILT1, LILRA2 | 53 kDa | monocytes | activation of NK cell–mediated cytotoxicity, association with FcRγ | |
CD85i | LIR6, LILRA1 | T cell subsets, monocytes, macrophages, DCs, B cells | inhibitory receptor for MHC class I antigens | ||
CD85j | LIR1, ILT2, MIR7 | 110 kDa | NK cells, DCs, monocytes, T cells | putative inhibitory receptor | |
CD85k | LIR5, ILT3, HM18, LILRB4 | 60 kDa | DCs, macrophages, monocytes, plasmacytoid DCs | association with FcRγ | |
CD85l | ILT9, LILRP1 | NK cells, T cell subsets, monocytes, macrophages, DCs, B cells | association with FcRγ | ||
CD85m | ILT10 | NK cells, T cell subsets, monocytes, macrophages, DCs, B cells | |||
CD86 | B70, B7-2 | 80kD | IgSF | mono, DC, Bact and Tact | binds to CD28, CD152, T costimulation |
CD87 | UPA-R | 39-66kD | GPI-linked | granulocytes, monocytes, macrophages, T cells, NK cells, wide variety of non-hematopoietic cell types | urokinase plasminogen activator receptor, inflammatory cell invasion, metastasis |
CD88 | C5aR | 43kD | TM7SF | polymorphonuclear leukocytes, macrophages, mast cells | C5a receptor, granulocyte activation |
CD89 | FcalphaR | 55-75kD | IgSF | mono, mac, gran, neutrophils, B subset, T subset | IgA receptor, phagocytosis, degranulation, respiratory burst |
CD90 | Thy-1 | 25-35kD | IgSF, GPI-linked | CD34+ hematopoietic subset, neurons | hematopoietic stem cell and neuron differentiation |
CD91 | 515, 85kD | LDLR family | mono, mac, neurons, fibroblasts | receptor for alpha-2-macroglobulin | |
CD92 | GR9 | 70kD | neutrophils, mono, platelets, endothelium, fibroblasts | unknown | |
CD93 | GR11 | 120kD | neutrophils, mono, endothelium | unknown | |
CD94 | KP43 | 43kD | C-type lectin | NK, T subset | complex with NKG2, inhibits NK function |
CD95 | Apo-1, Fas | 45kD | TNFRSF | lymph (high upon activation), mono, neutrophils | FasL (CD178) receptor, apoptosis |
CD96 | TACTILE | 160kD | IgSF | NK, Tact | adhesion of activated T and NK |
CD97 | GR1 | 75-85kD | TM7SF | Bact and Tact, mono, gran | binds CD55 |
CD98 | 4F2 | 80, 40kD | T, B, NK, gran, all human cell lines | cellular activation | |
CD99 | MIC2, E2 | 32kD | peripheral blood lymphocytes, thymocytes | T cell activation, adhesion | |
CD99R | E2 | 32kD | T, NK, myeloid cells | isoform of CD99 | |
CD100 | GR3 | 150kD | hematopoietic cells except immature bone marrow cells, RBC and platelets | cell adhesion, cellular activation | |
CD101 | V7, p126 | 120kD | IgSF | mono, gran, DC, Tact | T cell activation |
CD102 | ICAM-2 | 55-65kD | IgSF | lymph, mono, platelets, endoth | binds CD11a / CD18, costimulation |
CD103 | HML-1, alpha6, integrin alphaE | 150, 25kD | Integrin family | intraepithelial lymph, lymph subset, activated lymph | with integrin beta7, binds E-cadherin, lymph homing/retention |
CD104 | beta4 integrin | 220kD | Integrin family | epith, Schwann cells, keratinocytes, some tumor cells | with integrin alpha6 (CD49f), cell adhesion, differentiation, metastasis |
CD105 | Endoglin | 95kD | homodimer | endoth, bone marrow subset, activated mac | cellular response to TGF-beta1 |
CD106 | VCAM-1 | 110kD | IgSF | activated endoth, FDC | VLA-4 (CD49d / CD29) receptor, leukocyte adhesion, migration, costimulation |
CD107a | LAMP-1 | 110kD | activated platelets, T, endoth, metastatic tumors | a lysosomal membrane protein | |
CD107b | LAMP-2 | 120kD | activated platelets, T, endoth, metastatic tumors | a lysosomal membrane protein | |
CD108 | GR2, John Milton-Hagen blood group antigen | 80kD | erythrocytes, lymphoblasts, resting lymphlow | unknown | |
CD109 | platelet activation factor, GR56 | 170kD | Tact and platelets, CD34+ subset, endoth | unknown | |
CD110 | MPL, TPO-R | 82-84kD | CRSF | megakaryocytes, platelets, some CD34+ stem cellslow | thrombopoietin receptor, megakaryocyte progenitor cell growth / differentiation |
CD111 | PRR1, Nectin-1 | 64-72kD | IgSF | stem cell subset, mac, neutrophils | |
CD112 | PRR2, Nectin-2 | 64-72kD | IgSF | mono, neutrophils, CD34+ subset, megakaryocytes, endoth, epith | intercellular adhesion |
CD113 | PVRL3, Nectin3 | 83kD | IgSF | testis, placenta | adhesion molecule that interacts with afadin |
CD114 | G-CSFR | 150kD | CRSF | myeloid progenitors, granulocytes, monocytes | myeloid differentiation / proliferation |
CD115 | M-CSFR, c-fms | 150kD | IgSF, RTK family | mono, mac, monocytic progenitors | CSF-1R, monocytic differentiation / proliferation |
CD116 | GM-CSFRalpha | 70-85kD | CRSF | monocytes, neutrophils, eosinophils, endothelium | with common beta, myeloid differentiation / proliferation |
CD117 | c-kit, SCFR | 145kD | IgSF, RTK family | hematopoietic progenitors, mast cells | SCF receptor, hematopoietic progenitor development / differentiation |
CD118 | LIFR, gp190 | 190kD | Type I CRSF & secreted forms | epithelial cells in adult and embryo | membrane-bound involved in signal transduction, soluble form inhibits activity of LIF |
CD119 | IFNgammaR | 90-100kD | mac, mono, B, T, NK, neutrophils, endoth | IFN-gamma Ralpha, with IFN-gamma AF-1, host defense | |
CD120a | TNFR-I | 50-60kD | TNFRSF | hematopoietic, non-hematopoietic cells | receptor for both TNF-alpha and TNF-beta |
CD120b | TNFR-II | 75-85kD | TNFRSF | hematopoietic, non-hematopoietic cells | receptor for both TNF-alpha and TNF-beta |
CD121a | IL-1R type I | 80kD | IgSF | thymocytes, T cells | binds IL-1alpha and IL-1beta, IL-1 signaling |
CD121b | IL-1R, type II | 60-70kD | IgSF | B, mac, mono, T subset | binds IL-1alpha and IL-1beta, negative signals |
CD122 | IL-2Rbeta | 75kD | CRSF | NK, T, B, mono | IL-2Rbeta and IL-15Rbeta, signal transduction |
CD123 | IL-3R | 70kD | CRSF | lymph subset, basophils, hematopoietic progenitors, mac, DC, megakaryocytes | IL-3Ralpha, with CDw131 |
CD124 | IL-4R | 130-150kD | CRSF | lymphlow, mono, hematopoietic precursors, fibroblast, epith | IL-4Ralpha, with CD132 or IL-13Ralpha, T cell growth / differentiation |
CD125 | IL-5R | 60kD | CRSF | eosinophils, basophils | IL-5Ralpha, with CDw131 |
CD126 | IL-6R | 80kD | IgSF, CRSF | Bact and plasma cells, most leukocyteslow, fibroblasts | IL-6Ralpha, with CD130 |
CD127 | IL-7R | 65-75kD | CRSF | bone marrow lymphoid precursors, pro-B cells, mature T cells, monocytes | IL-7Ralpha, with CD132, B and T cell development |
CD128 | IL-8R | 58-67kD | |||
CD130 | IL-6Rbeta, gp130 | 130kD | CRSF | Bact and plasma cells, most leukocyteslow, endoth | IL-6Rbeta, IL-6, IL-11, LIF, CNF signals |
CD131 | IL-3R common beta | 140kD | CRSF | mono, gran, early B | with alpha subunits of IL-3R, IL-5R, and GM-CSFR, signal transduction |
CD132 | Common gamma | 64kD | CRSF | T, B, NK, mono, gran | subunit of IL-2R, IL-4R, IL-7R, IL-9R, and IL-15R, signal transduction |
CD133 | AC133, prominin-like 1 | 120kD | TM5SF | hematopoietic stem cell subset, epith, endoth | unknown |
CD134 | OX-40 | 48-50kD | TNFRSF | Tact | T cell activation, differentiation, apoptosis |
CD135 | Flt3/Flk2 | 130-150kD | RTK family | myelomonocytic, primitive B progenitors | tyrosine kinase, binds FLT3 ligand, early lymph development |
CD136 | MSP-R, RON | 180kD | RTK family | epith, CNS, PNS, hematopoietic subset | migration, morphological change and proliferation of different target cells |
CD137 | 4-1BB | 30kD | TNFRSF | Tact | T costimulation |
CD138 | Syndecan-1 | 80-150kD | Syndecan family | plasma cells, pre-B, basolateral surface of epith, neurons | receptor for ECM, cell morphology |
CD139 | 229, 228kD | B, mono, gran, erythrocyteslow | unknown | ||
CD140a | PDGFRalpha | 180kD | RTK family | stromal cells, some endothelial cells | binds PDGF A and B |
CD140b | PDGFRbeta | 180kD | RTK family | stromal cells, some endothelial cells | binds PDGF B |
CD141 | Thrombomodulin | 105kD | C-type lectin | mono, neutrophils, endoth, smooth muscle cells | initiation of protein C anticoagulant signal |
CD142 | Tissue Factor | 45-47kD | mono, endoth, keratinocytes, epith | binds clotting factor VIIa, initiator of clotting | |
CD143 | ACE | 170-180kD | endoth, epith, neurons, fibroblasts, activated mac | angiotensin converting enzyme, angiotensin II & bradykinin metabolism | |
CD144 | VE-Cadherin, Cadherin-5 | 130kD | Cadherin family | endoth | adhesion, cell-cell interaction |
CD145 | 25, 90, 110kD | endoth, some stromal cells | |||
CD146 | MUC18, S-endo | 130kD | IgSF | endoth, melanomas, FDC, Tact | adhesion |
CD147 | Neurothelin, basoglin | 55-65kD | IgSF | leukocytes, erythrocytes, platelets, endoth | adhesion |
CD148 | HPTP-eta | 240-260kD | gran, mono, DC, T (high upon activation) | tyrosine phosphatase R Type III | |
CD150 | SLAM | 75-95kD | IgSF | T subset (high upon activation), B, DC, endoth | costimulation, proliferation, Ig production, measles virus receptor |
CD151 | PETA-3 | 32kD | endoth, megakaryocytes, platelets, epith | cell adhesion | |
CD152 | CTLA-4 | 33kD | IgSF | Tact and B | CD80 and CD86 receptor, negative regulation of T cell costimulation |
CD153 | CD30L | 40kD | TNFSF | neutrophils, B, Tact and mac | CD30 ligand, T costimulation |
CD154 | CD40L, gp39, TRAP | 32-39kD | TNFSF | Tact | CD40 ligand, B and DC costimulation |
CD155 | PVR | 80-90kD | IgSF | mono, mac, CD34+ thymocytes | Polio virus receptor (PVR) |
CD156a | ADAM8 | 69kD | neutrophils, mono | leukocyte extravasation | |
CD156b | TACE / ADAM 17 | 100kD | broad | cleaves membrane proteins (TNF, TGFalpha) to generate soluble forms | |
CD156c | ADAM10 | 98kD | Peptidase M12B family | lymphoid organs, peripheral blood leukocyte, cartilage, chondrocytes and fetal liver | proteolytic cleavage of cell-surface molecules including Notch, TNF-alpha, APP and ephrin-A2 |
CD157 | BST-1 | 42-45kD | granulocytes, monocytes, bone marrow stromal cells, vascular endothelial cells, follicular dendritic cells | ADP-ribosyl-cyclic ADP-ribose hydrolase activities, pre-B cell growth | |
CD158a | p58.1 | 50-58kD | IgSF, KIR family | NK subset, T subset | inhibition of NK cell cytolytic activity, MHC class-I specific NK receptor |
CD158b | p58.2 | 50-58kD | IgSF, KIR family | NK subset, T subset | inhibition of NK cell cytolytic activity, MHC class-I specific NK receptor |
CD159a | NKG2A | 43kD | T subset, NK | with CD94, NK cell receptor | |
CD159c | NKG2C | 40kD | Type II C-Type Lectin | NK | with MHC class I HLA-E molecules, forms heterodimer with CD94 |
CD160 | BY55 | 27kD | IgSF | NK subset, T subset | costimulation |
CD161 | NKR-P1A | 40kD | C-type lectin | T subset, NK | NK cell-mediated cytotoxicity |
CD162 | PSGL-1 | 120kD | Mucin family | mono, gran, most lymph | CD62P, CD62L ligand, adhesion, rolling |
CD162R | PEN-5 | CHO | NK subset | unknown | |
CD163 | 130kD | 130kD | Scavenger receptor SF | mono, mac | unknown |
CD164 | MGC-24 | 80kD | epith, mono, lymphlow, bone marrow stromal cells, CD34+ erythroid progenitors | hematopoietic progenitor cell-stromal cell interaction | unknown |
CD165 | AD2, gp37 | 37kD | lymph subset, mono, immature thymocytes, platelets | adhesion, thymocyte-thymic epith interaction | adhesion between thymocytes and thymic epithelium |
CD166 | ALCAM | 105kD | IgSF | neurons, mono, epith, fibroblasts, Tact | CD6 ligand, adhesion |
CD167a | DDR1 | 63, 64kD | RTK family | epith, myoblasts | tyrosine kinase, adhesion to collagen |
CD168 | RHAMM | Five isoforms: 58, 60, 64, 70, 84 kD | mono, T subset, thymocyte subset, intracellularly in breast cancer cells | adhesion, tumor migration, metastasis | |
CD169 | sialoadhesin, Siglec-1 | 185kD | IgSF, sialoadhesins | tissue mac subset | adhesion, cell-cell and cell-matrix interactions, binds CD227 on breast cancer cells and CD43 on T cells |
CD170 | Siglec-5, CD33-like2 | 67 kD homodimer | IgSF, sialoadhesins | Mac subset, neutrophils | adhesion |
CD171 | L1 | 200-210kD | IgSF | CNS, PNS, glial cells, mono, T subset, B, DC, several human tumor cells | kidney morphogenesis, lymph node architecture, T costimulation, neurohistogenesis, homotypic interaction, binds CD9, CD24, CD56, CD142, CD166, integrins |
CD172a | SIRPgamma | 110kD | mono, T subset, stem cells | adhesion, complex with CD47 | |
CD172b | SIRPbeta, SIRB1 | 50kD | IgSF | mono and DC | negative regulation of RTK-coupled signaling |
CD172g | SIRPgamma, SIRPB2 | 45-50kD | IgSF, ASV | mRNA: liver and at lower levels in many tissues | binds CD47 |
CD173 | Blood group H type 2 | CHO | all cells | blood group H type 2; carbohydrate moiety | |
CD174 | Lewis Y | CHO | all cells | Lewis y Blood group; carbohydrate moiety | |
CD175 | Tn | CHO | all cells | Tn blood group; carbohydrate moiety | |
CD175s | Sialyl-Tn | CHO | all cells | sialyl-Tn blood group; carbohydrate moiety | |
CD176 | Thomson Friedenreich Ag | CHO | all cells | TF blood group; carbohydrate moiety | |
CD177 | NB1 | 56-62kD | neutrophil subset | ||
CD178 | FasL, CD95L | 38-42kD | TNFSF | Tact, testis | CD95 ligand, apoptosis, immune privilege, soluble form in serum |
CD179a | V pre B | 16-18kD | IgSF | Pro- and Pre-B | B cell differentiation / signaling, with IgM |
CD179b | Lambda 5 | 22kD | IgSF | Pro- and Pre-B | B cell differentiation / signaling, with IgM |
CD180 | RP-105 | 95-105kD | LRRF, TLR family | B subset, mono, DC | B cell activation, LPS signaling, with MD-1 |
CD181 | CXCR1, IL-8RA | 39kD | GPCR1 family | neutrophils, basophils, NK, T subset, mono | binding of IL-8 induces chemotaxis of neutrophils |
CD182 | CXCR2, IL-8RB | 40kD | GPCR1 family | neutrophils, basophils, NK, T subset, mono | binding of IL-8 induces chemotaxis of neutrophils |
CD183 | CXCR3 | 46-52kD | TM7SF | eosinophils, Tact and NK, GM-CSF activated CD34+ progenitors | IP-10 , Mig and I-TAC receptor, T cell recruitment to inflammatory sites, enhancement of Th1 response |
CD184 | CXCR4, fusin | 46-52kD | TM7SF | B, DC, T subset, mono, endoth | SDF-1 receptor, X4 HIV-1 coreceptor |
CD185 | CXCR5, BLR1 | 45kD | GPCR1 family | mature B and Burkitt Lymphoma cells | with chemokine BLC, possible regulatory function in Burkitt Lymphomagenesis and/or B differentiation, activation of mature B |
CD186 | CXCR6, BONZO | 40kD | GPCR1 family | Tact | receptor for CXCL16 and coreceptor for SIV, strains of HIV-2 and m-tropic HIV-1 |
CD191 | CCR1, MIP-1alphaR, RANTES-R | 39kD | GPCR1 family | T, mono, stem cell subset | binds C-C type chemokines and transduces signal by increasing intracellular calcium ion levels |
CD192 | CCR2, MCP-1-R | 40kD | GPCR1 family | activated NK and mononuclear phagocytes, T subset, B, endoth | binds MCP-1, MCP-3 & MCP-4, alternative coreceptor with CD4 for HIV-1 infection |
CD193 | CCR3, CKR3 | 45kD | GPCR1 family | eosinophils, lower expression in neutrophils and mono, T subset | binds eotaxin, eotaxin-3, MCP-3, MCP-4, RANTES & MIP-1delta, alternative coreceptor with CD4 for HIV-1 infection |
CD195 | CCR5 | 40kD | mono, T subset | MIP-1alpha, MIP-1beta and RANTES receptor, R5 HIV-1 coreceptor | |
CD196 | CCR6, LARC receptor, DRY6 | 45kD | GPCR1 family | T subset, B, DC subset | binds MIP-3alpha/LARC |
CD197 | CCR7 | 45kD | T subset, DC Subset | 6Ckine and MIP-2beta receptor | |
CD198 | CCR8, GPRCY6, TER1 | 50kD | GPCR1 family | T, high expression in Th2, NK, mono | allergic inflammation, alternative coreceptor with CD4 for HIV-1 infection |
CD199 | CCR9, GPR-9-6 | 43kD | GPCR1 family | subset of memory T, lamina propria mononuclear cells | binds SCYA25/TECK, alternative coreceptor with CD4 for HIV-1 infection |
CD200 | OX-2 | 45-50kD | thymocytes, endoth, B, Tact | inhibition of immune response | |
CD201 | EPC-R | 50kD | endoth subset | activated protein C receptor | |
CD202b | Tie2, Tek | 150kD | RTK family | stem cells, endoth | angiopoietin-1 receptor |
CD203c | NPP3 / PDNP3, ENpp1, PD-1b | 101kD | type II TM | basophils, mast cells, glioma cells, megakaryocytes | ectoenzyme, binding to and clearance of extracellular nucleotides |
CD204 | Macrophage scavenger-R | 220kD | mac | endocytosis of macromolecules | |
CD205 | DEC-205 | 205kD | DC, thymic epith | DC, thymic epith | |
CD206 | macrophage mannose-R | 175-190kD | DC subset, mac, mono | phagocytosis and pinocytosis of mannose containing molecules | |
CD207 | Langerin | 40kD | Langerhans cells | endocytic receptor | |
CD208 | DC-LAMP | 70-90kD | DCact, interdigitating DC | ||
CD209 | DC-SIGN | 44kD | DC subset | ICAM-3 receptor, HIV-1 binding protein | |
CD210 | IL-10-R | 90-110kD | T, B, NK, mono, mac | IL-10 receptor, signal transduction | |
CD212 | IL-12-R beta1 | 130kD | activated CD4, CD8, and NK cells | binds IL-12 with high affinity, associates with IL-12 receptor beta2 | |
CD213a1 | IL-13-R alpha1 | 60-70kD | B cells, monocytes, fibroblasts, endothelial cells | binds IL-13 with low affinity, with CD124 | |
CD213a2 | IL-13-R alpha2 | 65kD | B cells, monocytes, fibroblasts, endothelial cells | binds IL-13 with high affinity | |
CD215 | IL15R, interleukin 15 receptor α | 28 kDa | brain tissue, activated monocytes, macrophages, NK cells | high-affinity receptor for IL-15, signal transduction, development and survival of NK cells | |
CD217 | IL-17-R | 120kD | Activated memory T cells | IL-17 receptor | |
CD218a | IL-18Ralpha, IL-1Rrp | 70kD | IL-1R family | T, NK, DCs | binds IL-18, activation of NF-kappaB |
CD218b | IL-18Rbeta, IL18RAP | 70kD | IL-1R family | T, NK and DCs | heterodimeric receptor with IL-18Ralpha to enhance IL-18 binding |
CD220 | Insulin-R | 140, 70kD | nonlineage molecules | insulin receptor | |
CD221 | IGF-1 R | α: 135 kD, β: 90 KD | nonlineage molecules | binds IGF with high affinity, signaling, cell proliferation/ differentiation | |
CD222 | IGF-II R, mannose-6 phosphate-R | 250kD | Type I TM | nonlineage molecules | adhesion, tumor growth, a receptor for TGFbeta-LAP, plasminogen, proliferin, truncated form (220kD) found in serum |
CD223 | LAG-3 | 70kD | IgSF | Tact and NK | an MHC class II ligand |
CD224 | GGT | 27, 68kD | leukocytes, stem cells | ||
CD225 | Leu-13 | 17kD | broad | ||
CD226 | DNAM-1, PTA-1, TLiSA1 | 65kD | IgSF | T, NK, mono, platelets, activated HUVEC | activation of cell-mediated cytotoxicity, soluble form (50kD) found in normal serum |
CD227 | MUC1, EMA | 300kD | Mucin family, type I TM | epith, stem cell subset, FDC, mono, B subset, some myelomas | adhesion, signaling, binds CD169, CD54, & selectins |
CD228 | Melanotransferrin | 80-95kD | stem cells, melanomas | tumor-associated antigen (melanoma), involved in Iron uptake | |
CD229 | Ly-9 | 95, 110kD | IgSF | T, B | adhesion |
CD230 | Prion protein | 35kD | broad | expressed both in normal and infected cells | |
CD231 | TALLA-1, A15 | 150kD | TM4SF | T leukemias, neuroblastomas, brain neurons | marker for T cell acute lymphoblastic leukemia |
CD232 | VESP-R | 200kD | broad | ||
CD233 | Band 3, SLC4A1 | 90kD | Anion exchanger family | erythrocytes | anion exchanger pump, transport of CO2, linking red cell membrane to cytoskeleton |
CD234 | Duffy, DARC | 35-45kD | erythrocytes | Duffy antigen chemokine receptor | |
CD235a | Glycophorin A | 31kD | erythrocytes | major carbohydrate-rich sialoglycoprotein of human erythrocyte membrane | |
CD235ab | Glycophorin A/B | 20kD | erythrocytes | minor sialoglycoprotein in human erythrocyte membranes | |
CD235b | Glycophorin B | 20kD | erythrocytes | ||
CD236 | Glycophorin C/D | 32, 23kD | erythrocytes, stem cell subset | ||
CD236R | Glycophorin C | 32kD | erythrocytes, stem cell subset | plays an important role in regulating the mechanical stability of red cells and is a putative receptor for the merozoites of Plasmodium falciparum | |
CD238 | Kell | 93kD | erythrocytes, stem cell subset | KELL blood group antigen; homology to a family of zinc metalloglyco-proteins | |
CD239 | B-CAM | 78-85kD | erythrocytes, stem cell subset | a type I membrane protein, upregulated following malignant transformation in some cell types | |
CD240CE | Rh30CE | 30-32kD | erythrocytes | may be part of an oligomeric complex, which is likely to have a transport or channel function in the erythrocyte membrane | |
CD240D | Rh30D | 30-32kD | TM12SF | erythrocytes | may be part of an oligomeric complex, which is likely to have a transport or channel function in the erythrocyte membrane |
CD241 | RhAg, Rh50 | 50kD | TM12SF | erythrocytes | may be part of an oligomeric complex, which is likely to have a transport or channel function in the erythrocyte membrane |
CD242 | ICAM-4 | 42kD | IgSF | erythrocytes | adhesion, Landsteiner-Wiener blood group |
CD243 | MDR-1, p170, P-gp | 170kD | stem cells, small intestine, kidney stem cells, small intestine, kidney | ion pump | |
CD244 | 2B4 | 66kD | type II TM | T subset, mono, basophils, NK | NK activation, CD48 ligand |
CD245 | p220/240 | 220-240kD | T subset | ||
CD246 | ALK, Ki-1 | 177kD | anaplastic T cell leukemias, small intestine, testis, brain, not on normal lymph | brain development, implicated in ALK lymphomas | |
CD247 | TCRz | 16kD | RTK family | T, NK | TCR complex subunit, coupling of antigen recognition to signaling |
CD248 | TEM1, Endosialin | 175kD | C-Type Lectin | endothelial tissue, stromal fibroblasts | tumor progression and angiogenesis |
CD249 | Aminopeptidase A | 160kD | Peptidase M1 family | epith, endoth | renin-angiotensin system |
CD252 | OX-40Ligand, gp34 | 34kD | TNFSF | Bact, cardiac myocytes | T costimulation |
CD253 | TRAIL, Apo-2L, TL2, TNFSF10 | TNFSF | Tact, many tissues | apoptosis | |
CD254 | TRANCE, RANKL, OPGL | 35kD | TNFSF | lymph node & BM stroma Tact | binds OPG and RANK, osteoclast differentiation, enhances DC to stimulate naïve-T proliferation |
CD256 | APRIL, TALL-2 | 16kD | TNFSF | leukocytes, pancreatic cells, mono, mac | binds TACI & BCMA, B proliferation , aids metastasis |
CD257 | BLyS, BAFF, TALL-1 | TNFSF | B cells, plasma cells, mono, mac, T cells and DCs | costimulator of B cells, T cells and Ig production | |
CD258 | LIGHT, HVEM-L | 28kD | TNFSF | Tact, immature DC | binds LTBR, T proliferation, receptor for HVEM |
CD261 | TRAIL-R1, DR4 | 57kD | TNFRSF | Tact, peripheral blood leukocytes | contains death domain, apoptosis via FADD & caspase-8 |
CD262 | TRAIL-R2, DR5 | 60kD | TNFRSF | widely expressed, peripheral blood lymphocytes | contains death domain, apoptosis via FADD and caspase-8 |
CD263 | TRAIL-R3, DcR1, LIT | 65kD | TNFRSF | peripheral blood lymphocytes | receptor for TRAIL but lacks death domain |
CD265 | RANK, TRANCE-R, ODFR | 97kD | TNFRSF | broad expression | binds TRANCE, osteoclastogenesis ,T-DC interactions, suppresses apoptosis |
CD266 | TWEAK-R, FGF-inducible 14 | 14kD | TNFRSF | heart, placenta and kidney, HUVEC | TWEAK receptor, cell-matrix interactions and endoth growth and migration |
CD267 | TACI, TNFR SF13B | B, Tact | binds BAFF & APRIL | ||
CD268 | BAFFR, TR13C | 25kD | TNFRSF | B | binds BLyS, mature B survival |
CD269 | BCMA, TNFRSF13B | 20kD | TNFRSF | mature B (membrane and perinuclear) | receptor for CD256 and CD257, B survival & proliferation |
CD271 | NGFR, p75 (NTR) | 45kD | TNFRSF | neurons (schwann cells, growing neurites), BM mesenchymal cells | NGF, BDNF, NT-3, & NT-4 receptor, tumor suppressor, cell survival and death |
CD272 | BTLA | 33kD | IgSF | Tact, B , remains on Th1 | HVEM receptor, inhibitory response |
CD273 | B7DC, PD-L2, PDCD1L2 | 25kD | IgSF | DC subset, mono, mac | PD-1 receptor, costimulation or suppression of T proliferation |
CD274 | B7-H1, PD-L1 | 33kD | IgSF | leukocytes, broad | PD-1 receptor, costimulation of lymphocytes |
CD275 | B7-H2, ICOSL, B7-RP1, GL50 | 60kD | B7 Family | B, DC, mono | costimulation, cytokine production, ligand for CD278 |
CD276 | B7-H3 | 40-45kD | B7 Family, ASV | in vitro cultured DC and mono, Tact, mammary tissue | costimulation, T activation |
CD277 | BT3.1, butyrophilin SF3 A1, BTF5 | 56kD | B7/BT family, ASV | T, B, NK, mono, DC, endoth, CD34+ cells, tumor cell lines | T activation |
CD278 | ICOS, AILIM | 55-60kD | CD28 family | Tact, Th2 | binds ICOS-L, T costimulation |
CD279 | PD1, SLEB2 | 55kD | Tact and Bact | B7-H1 & B7-DC receptor, autoimmune disease and peripheral tolerance | |
CD280 | ENDO180, UPARAP | 180kD | C-type lectin SF | chondrocytes, fibroblasts, endothelial, mac | mannose receptor, collagen matrix remodeling and endocytic recycling |
CD281 | TLR1 | 90kD | TLR family | low levels in PBMC, mono and possibly DC | innate immunity, with TLR2 |
CD282 | TLR2 | 90kD | TLR family | mono, neutrophil, upregulated in mac | binds dsRNA, response to bacterialli poproteins, innate immunity, induces IFN secretion |
CD283 | TLR3 | 100kD | TLR family, ASV | alveolar macrophages | binds dsRNA, innate immunity |
CD284 | TLR4 | 100kD | TLR family, ASV | PBMC (weak in mono, immature DC & neutro), neuronal cells | binds LPS, innate immunity, development of nervous system |
CD289 | TLR9 | 120kD | TLR family | pre DC (intracellular), PB leukocytes | binds CpG-DNA, innate immunity |
CD290 | TLR10 | 90 kDa | B cells, monocytes, Treg cells, pDCs | pathogen recognition, activation of innate immunity | |
CD292 | BMPR1A, ALK3 | 57kD | Type I | bone progenitor | BMP 2 & 4 receptor, bone development, apoptosis |
CD293 | BMPR1B, ALK6 | 57kD | Type I, ASV | bone progenitor | BMP receptor, bone development |
CD294 | CRTH2. GPR44 | 55-70kD | GPCR-7TM | Th2, eosinophils, basophils | binds prostaglandin D2, stimulatory effects on Th2, allergic inflammation |
CD295 | LeptinR, LEPR | 132kD | Type I cytokine-like receptor | broad | adipose metabolism, immune dysfunction in obesity, receptor for Leptin |
CD296 | ART1, RT6, ART2 | 37kD | ADP- ribosyl transferase | heart and skeletal muscle, peripheral T, NK subset | modifies integrins during differentiation, ADP ribosylation of target proteins |
CD297 | ART4, dombrock blood group | 38kD | ADP- ribosyl transferase | erythroid, monoact | ADP ribosylation of target proteins |
CD298 | Na+/K+-ATPase beta3 subunit | 52kD | broad | transport sodium & potassium ions across membrane | |
CD299 | DC-SIGN-related, LSIGN, DC-SIGN2 | 45kD | Type II, similar to CD209, ASV | endothelial subset | binds ICAM3, HIV-1 gp120, coreceptor with DC-SIGN, HIV infection |
CD300a | CMRF35H, IRC1, IRp60 | 60kD | IgSF, ASV | NK, mono, neutrophils, T and B subset and lymphocytic cell lines, AML | unknown |
CD300c | CMRF35A, LIR | IgSF | mono, neutrophils, monocytic cell lines, B & T subsets | unknown | |
CD300e | CMRF35L | IgSF CMRF family | monocytes, macrophages and DCs | unknown | |
CD300f | IREM1, MAIR-V | 60 kDa | myeloid | inhibitory receptor | |
CD301 | MGL, HML | 38kD | C type lectin SF, ASV | mac, mono, immature DCs | binds Tn antigen, uptake of glycosylated antigens innate immunity |
CD302 | DCL1, BIMLEC | 19-28kD | Type I TM C-type lectin receptor | monocytes, macrophages, DCs and granulocytes. Hodgkin's cell lines | a fusion protein in Hodgkin’s lymphoma with DEC-205, cell adhesion, phagocytosis |
CD303 | BDCA2, HECL | 38kD | C-type lectin SF ASV | plasmacytoid dendritic cells | inhibit IFN-alpha production , cytokine production in PDCs |
CD304 | BDCA4, neuropilin 1 | 130kD | semaphorin family | neurons, CD4+/CD25+ Treg, DC, endothelial and tumor cells | interacts with VEGF165 & semaphorins, co-receptor with plexin, axonal guidance, angiogenesis, cell survival, migration |
CD305 | LAIR1 | 32-40kD | IgSF, ASV | NK, B, T, mono, mac | inhibitory receptor on NK and T cells |
CD306 | LAIR2 | IgSF, ASV | NK, B, T, mono, mac | soluble, mucosal tolerance | |
CD307 | IRTA2 | 55-105kD | IgSF (Fc receptor), ASV | B subset, B lymphoma | B cell development, translocation in some lymphomas |
CD307a | FCRL1, Fc receptor-like 1, FCRH1, IFGP1, IRTA5, FCRL1 | 50 kDa | mature B cells | putative role in B cell activation and differentiation – | |
CD307b | FCRL2, Fc receptor-like 2, FCRH2, IFGP4, IRTA4, SPAP1, SPAP1A, SPAP1B, SPAP1C | 55 kDa | memory B cells | putative role in B cell development | |
CD307c | FCRL3, Fc receptor-like 3, FCRH3, IFGP3, IRTA3, SPAP2 | 89 kDa | B and NK cells | unknown | |
CD307d | FCRL4, Fc receptor-like 4, FCRH4, IGFP2, IRTA1 | 57 kDa | memory B cells | may inhibit B cell receptor | |
CD307e | FCRL5, Fc receptor-like 5, CD307, FCRH5, IRTA2, BXMAS1, PRO820 | 106 kDa | B cells | putative role in B cell development and differentiation | |
CD309 | VEGFR2, KDR | 230kD | Type III TM tyr kinase | endothelial, angiogenic precursor cells, hemangioblast | binds VEGF, regulates adhesion and cell signaling, proliferation, migration and differentiation |
CD312 | EMR2 | 90kD | EGFR-7TM ASV | mono, mac, moDC, granslow | cell adhesion and migration for phagocytosis |
CD314 | NKG2D, KLR | 42kD | Type II lectin-like receptor | NK, CD8+ activated, NK1.1+ T, some myeloid cells | binds MHC class I, MICA, MICB, Rae1 & ULBP4, activates cytolysis and cytokine production, costimulation |
CD315 | CD9P1, SMAP6, FPRP, PTGFRN | 135kD | IgSF | megakaryocytes, hepatocytes, epithelial cells and endothelium | Angiogenesis |
CD316 | EWI2, PGRL, CD81P3, KASP | 63-75kD | IgSF8 | B, T cells, low on NK cells | with CD81 & CD9; involved in cell migration |
CD317 | BST2, HM1.24 | 30-36kD | Type II | B, T, NK, mono, DC, fibroblast cell line, myeloma | pre-B cell growth, overexpressed in multiple myeloma |
CD318 | CDCP1, SIMA135 | 135kD | Type I, ASV | HSC (subset of CD34+), tumors | cell adhesion with ECM, metastasis |
CD319 | CRACC, SLAMF7 | 66kD | Ig TM | T, B and DC subset, NK, upregulated in DC | regulate T and NK cells |
CD320 | 8D6A, 8D6 | 30kD | LDL receptor | follicular DC, germinal centers | B proliferation, tumor formation |
CD321 | JAM1, F11 receptor | 35kD | IgSF, Type I, ASV | platelet receptor, epithelia and endothelial, platelets | tight junctions, cell proliferation and migration |
CD322 | JAM2, VE-JAM | 43kD | IgSF | HEV, other endoth | cell adhesion, lymphocyte homing to secondary lymphoid organs |
CD324 | E-Cadherin, Uvomorulin | 120kD | cadherin SF | no neutral epithelial cells, keratinocytes, and platelets | cell adhesion, homotypic interaction & binds alphaE/beta7 |
CD325 | N-Cadherin, NCAD | 140kD | cadherin SF | brain, skeletal and cardiac muscle | cell adhesion, neuronal recognition |
CD326 | Ep-CAM, Ly74 | 35-40kD | most epith cell membranes | proliferation and differentiation of embryonic stem cells | |
CD327 | SIGLEC6 | IgSF | placenta, spleen, B . sialic-acid dependent | adhesion, membrane- bound & secreted forms | |
CD328 | SIGLEC7, AIRM-1 | 75kD | IgSF | resting and activated NK, placenta, liver, spleen, lower in gran & mono | sialic-acid dependent adhesion, inhibit NK activation, hemopoiesis |
CD329 | SIGLEC9 | IgSF | neutrophils and mono | sialic-acid dependent adhesion molecule | |
CD331 | FGFR1, Fms-like tyrosine kinase-2, KAL2, N-SAM | 30kD | TM tyr kinase | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors, muscle and bone development |
CD332 | FGFR2, BEK, KGFR | 115-135kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors |
CD333 | FGFR3, ACH, CEK2 | 115kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors |
CD334 | FGFR4, JTK2, TKF | 110kD | TM RTK family | fibroblasts, epithelial | binds FGF, high affinity receptor for fibroblast growth factors |
CD335 | NKp46, Ly-94 homolog | 46kD | IgSF | NK | activates NK cells upon non-MHC ligand binding |
CD336 | NKp44, Ly-95 homolog | 44kD | IgSF | NK | activates NK cells upon non-MHC ligand binding |
CD337 | NKp30, Ly117 | 30kD | IgSF | NK | activates NK cells upon non-MHC ligand binding |
CD338 | ABCG2, BCRP, Bcrp1, MXR | 73kD | GPCR 7TM | stem cell subset (side population) | multi-drug resistance transporter |
CD339 | Jagged-1, JAG1, JAGL1, hJ1 | 135kD | EGF TM | stromal cells, epithelial, AML | binds Notch, hematopoiesis |
CD340 | HER2/neu, ERBB2, p185HER2 | 185 kDa | bone marrow mesenchymal stem cells, endothelial cells, epithelial cells, keratinocytes | lymph node, spleen, thymus, bone marrow | |
CD344 | Frizzled-4, Fz-4, hFz-4, FzE4 | 59 kDa | adult kidney, lung, brain, liver, fetal neuronal cells, intestinal cells | activation of the Wnt/β-catenin pathway, regulation of tissue and cell polarity | |
CD349 | Frizzled-9, Fz-9, hFz-9 | 65 kDa | adult and fetal brain; testis, eye, skeletal muscle, and kidney; bone marrow mesenchymal stem cells | activation of the Wnt/β-catenin pathway, regulation of tissue and cell polarity | |
CD350 | Frizzled-10, Fz-10, hFz-10 | 65 kDa | placenta and kidney; fetal lung and brain | activation of the Wnt/β-catenin pathway, regulation of tissue and cell polarity | |
CD351 | FCAMR, Fc receptor of IgA and IgM, FCA/MR, FKSG87 | 57 kDa | mesangial cell | downregulates germinal center formation | |
CD352 | SLAMF6, SLAM family member 6, KALI, NTBA, KALIb, Ly108, NTB-A, SF2000 | 37 kDa | NK, T, and B cells | triggers cytolytic activity of NK cells | |
CD353 | SLAMF8, SLAM family member 8, BLAME, SBBI42 | 32 kDa | lymph node, spleen, thymus, bone marrow | putative role in B cell signaling and differentiation | |
CD354 | TREM1, triggering receptor expressed on myeloid cells 1, TREM-1 | 26 kDa | myeloid, hepatocytes, osteoclasts, microglia | stimulation of neutrophils and monocytes | |
CD355 | CRTAM, cytotoxic and regulatory T cell molecule | 45 kDa | NKact cells, CD8act cells, γδ T cells, Purkinje neurons | cytotoxicity, tumor rejection | |
CD357 | AITR, GITR, TNFRSF18, tumor necrosis factor receptor superfamily, member 18, GITR-D | 26 kDa | activated lymphocytes, T cell subsets | Cross-talk of lymphocytes and endothelial cells, T cell activation | |
CD358 | TNFRSF21, tumor necrosis factor receptor superfamily, member 21, DR6, BM-018 | 72 kDa | fetal spinal cord, brain | promotion of apoptosis, elevated in Alzheimer’s disease | |
CD360 | IL21R, interleukin 21 receptor, NILR | 59 kDa | B, T, and NK cells; DCs | signal transduction | |
CD361 | EVI2B, ecotropic viral integration site 2B, EVDB, D17S376 | 47 kDa | bone marrow, PBMCs, fibroblasts | cell-surface proteoglycan that bears heparan sulfate | |
CD362 | SDC2, syndecan 2, HSPG, HSPG1, SYND2 | 22 kDa | T cell migration | ||
CD363 | S1PR1, sphingosine-1-phosphate receptor 1, EDG1, S1P1, ECGF1, EDG-1, CHEDG1 | 42 kDa | lymphocytes, B cells, NK cells, monocytes/macrophages, endothelial cells, neural progenitors, neurons, astrocytes, oligodendrocytes | putative serine protease inhibitor | |
CD364 | PI16, peptidase inhibitor 16, dJ90K10.5, MGC45378, MSMBBP | 49 kDa | prostate, testis, ovary, intestine | role in Th cell development, involved in hepatitis A virus entry into cells | |
CD365 | TIM-1, HAVCR1, HAVCR-1, TIMD1 | 38 kDa | activated CD4+ T cells | inhibitory receptor on Th1 cells | |
CD366 | TIM-3, HAVCR2, TIMD3 | 33 kDa | Th1 cells, DC subsets | inhibitory receptor on DCs and B cells | |
CD367 | CLEC4A, DCIR, DDB27, CLECSF6 | 27 kDa | pDCs, myeloid cells, B cells | endocytic receptor | |
CD368 | CLEC4D, MCL, CLECSF8, CLEC-6, MPCL | 24 kDa | monocytes, macrophages | TLR2-mediated inflammatory response | |
CD369 | CLEC7A, DECTIN-1, CLECSF12 | 27 kDa | monocytes, macrophages, DCs, neutrophils, lymphocytes | endocytic receptor | |
CD370 | CLEC9A, HEEE9341, UNQ9341, DNGR1 | 27 kDa | DC subsets, monocyte subsets | signal transduction | |
CD371 | CLEC12A, CLL-1, myeloid inhibitory C-type lectin-like receptor (MICL), DCAL-2 | 30 kDa | neutrophils, eosinophils, monocytes, DCs | signaling through FCg |
Antigen name | Other names | MW | Structure | Distribution | Function |
---|---|---|---|---|---|
4-1BB Ligand | CD137L | TNFSF | Bact, DC, carcinoma cell lines | T costimulation | |
AID | RNA-editing deaminase family | Bact, Germinal Center B | Activation-Induced Deaminase, Ig class switch recombination | ||
AITR | TNFRSF18, GITR | Treg, Tact | costimulation | ||
AITRL | TNFSF18, TL6, GITRL | APC | |||
B7 family | see CD273-276 | ||||
B7-H4 | B7-S1, B7x | B7 family | may interact with BTLA (?), inhibition | ||
BAMBI | TGFBR | 29kD | TGFBR | carcinoma cell | pseudoreceptor for TGF-beta (short cytoplasmic domain), growth inhibition |
BCMA | see CD269 | ||||
BLyS | see CD257 | ||||
BR3 | see CD268 | ||||
BTLA | see CD272 | ||||
CCR7 | see CD197 | ||||
c-Met | HGFR/SFR | 190kD | heterodimer, PTK | epith, hematopoietic progenitors, early thymocytes | tumor growth / metastasis, Hepatocyte Growth Factor / Scatter Factor receptor, T development, hematopoiesis |
CMKLR1 | chemokine-like receptor 1 | 42kD | GPCR 7TM, chemokine receptor | pDC (CD123+), in vitro derived moDC | binds chemerin, pDC recruitment, bone development |
DcR3 | TR6, TNFRSF6B | Soluble | tumors | Fas decoy receptor, tumor evasion | |
DEC-205 | see CD205 | ||||
DR3 | TRAMP, Apo-3, WSL-1, LARD, TR3 | TNFRSF | Tact, leukocytes | lymphocyte homeostasis | |
DR6 | TR7 | TNFRSF | death, Th2 response | ||
Fc epsilonRI alpha | high-affinity IgE receptor | tetramer complex | mast cells, basophils | triggers IgE-mediated allergic reactions | |
Foxp3 | SCURFIN | 50kD | Fox family forkhead | T subsets (CD4+/CD25+ subset and CD8+ subset) | transcription factor, upregulated in T regs |
Granzyme B | Granzyme-2, CTLA-1 | 30kD | Peptidase S1 family | Cytotoxic T, NK | target cell apoptotic lysis, cell-mediated immune responses |
HLA-ABC | 45, 11-12kD | nucleated cells | cell-mediated immune response & tumor surveillance | ||
HLA-DR | APC, Tact | presentation of peptides to CD4+ T lymphocytes | |||
HVEM | TNFRSF14, TR2 | 60kD | TNFRSF | broad expression | receptor for LIGHT, LT-alpha, BTLA, Herpes Simplex Virus, lymphocyte activation |
ICOS | see CD278 | ||||
ICOSL | see CD275 | ||||
IL-15R alpha | monoact | binds to IL-15, w/ IL-2RB and common gamma, IL-15 trans-presentation | |||
Integrin beta5 | 100kD | carcinoma cell lines, fibroblast lines | w/ alphav subunit, vitronectin receptor | ||
MD-2 | 30KD | w/ TLR4 distribution and LPS recognition | |||
MICA/MICB | 70kD | MHC Class I-related proteins | intestinal epith, some tumors | unregulated on epith after shock, NKG2D receptors | |
Nanog | 34kD | ES cells | transcription factor, self renewal of ES cells | ||
NKG2D | see CD314 | ||||
NOD2 | CARD-15, IBD1 | monocytes, intracellular | |||
Notch-1 | Lin-12, Tan 1 | developing embryo, variety of adult tissues | cell-cell interaction, cell fate determination | ||
OPG | TRAIL-R5, TR1, TNFRSF11B | binds TRAIL? | bone resorption | ||
OX-40 | see CD134 | ||||
OX-40 Ligand | see CD252 | ||||
p38 | 38kD | SAP/MAP kinase | NK, CD8+ T subset, upregulated on CD8+T | role in cytolytic activity | |
PD-1 | see CD279 | ||||
PD-L1 | see CD274 | ||||
PD-L2 | see CD273 | ||||
Perforin | 70-75kD | CTL, NK | cytolytic protein | ||
RP105 | see CD180 | ||||
RANK | see CD265 | ||||
RANKL | see CD254 | ||||
SAP | SLAM-associated protein | 14kD | adaptor protein | T, NK | negatively regulates SLAM- family receptors |
SLP-76 | 76kD | T, Blow | T cell receptor mediated signaling | ||
SSEA-1 | stage-specific embryonic antigen-1 | ES cells, embryonic carcinomas, germ cells | down regulated by differentiation | ||
SSEA-3 | stage-specific embryonic antigen-3 | ||||
SSEA-4 | stage-specific embryonic antigen-4 | ||||
Stro-1 | BM stroma, erythroid progenitors | surface marker for immature mesenchymal cells | |||
TACI | see CD267 | ||||
T-bet | Th1 cells | transcription factor, T development / differentiation | |||
TCL1 | B cell tumors, lymphoid lineages in a developmentally controlled manner, pDC | intracellular, lymphoid proto-oncogene | |||
TCR alpha beta | peripheral T subset | antigen recognition | |||
TCR gamma delta | T subset | antigen recognition | |||
TLR1 - TLR4 | see CD281 - CD284 | ||||
TLR5 | TIL3 | TLR family | mRNA: leukocytes, prostate, ovary, liver, lung | interacts w/ microbial lipoproteins, NF-kappaB, responds to Salmonella | |
TLR6 | TLR family | mRNA: leukocytes, ovary, lung | interacts w/ microbial lipoproteins, protein sequence similar to hTLR1; regulates TLR2 response | ||
TLR7 | TLR family | mRNA: spleen, placenta, lung; upregulated on mac | |||
TLR8 | TLR family | mRNA: leukocytes, lung | |||
TLR9 | see CD289 | ||||
TLR10 | TLR family | mRNA: lymphoid tissues | most closely related to TLR1 and TLR6 | ||
TNFRI | see CD120a | ||||
TRAIL | see CD253 | ||||
TSLPR | 50kD | heterodimer with IL-7Ralpha/CD127 | monocytes, DC, B | binds TSLP (Thymic Stromal Lymphopoietin) to activate DC | |
TWEAK | TNFSF12, APO3L | TNFSF | activated mono | death | |
TWEAK Receptor | see CD266 | ||||
ULBPs | MHC class I-related proteins, GPI-linked | tumors | NKG2D receptors, NK activation | ||
ZAP-70 | TCRζ-associated kinase | 70kD | Syk family | Intracellular T, NK | TCR signaling & development |
This online tool guides you through flow cytometry panel design, providing a simplified, customizable experience to fit your flow cytometry panel design needs.
Contact our technical sales specialists for help choosing antibodies, fluorophores, and reagents for success on the flow cytometer you’ll be using.
For Research Use Only. Not for use in diagnostic procedures.